Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a Poly (adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor (043)

Autor:	Joan Tymon-Rosario, Paola Manara, Diego Manavella, Stefania Bellone, Eric Siegel, Tobias Hartwich, Justin Harold, Luca Arrigo Zammataro, Yang Yang-Hartwich, Levent Mutlu, Gary Altwerger, Gulden Menderes, Elena Ratner, Gloria Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter Schwartz, Ludmil Alexandrov, Alessandro Santin
Rok vydání:	2022
Předmět:	Oncology Obstetrics and Gynecology
Zdroj:	Gynecologic Oncology. 166:S30
ISSN:	0090-8258
DOI:	10.1016/s0090-8258(22)01262-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::860bdd03aa96e9e5b857ef0332a790cb https://doi.org/10.1016/s0090-8258(22)01262-8 Zobrazit plný text záznamu Full Text from ScienceDirect